当前位置: X-MOL 学术Gut Liver › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
Gut and Liver ( IF 3.4 ) Pub Date : 2021-04-09 , DOI: 10.5009/gnl20279
Hyun Jin Kim 1 , Seak Hee Oh 2 , Sung Hee Lee 2 , Yu-Bin Kim 2 , Dae Yeon Kim 3 , Sang Hyoung Park 4 , Byong Duk Ye 4 , Suk-Kyun Yang 4 , Kyung Mo Kim 2
Affiliation  

: Recently, the treatment of Crohn's disease (CD) has changed to a treat-totarget strategy, in which disease progression is prevented with early intervention. We analyzed the long-term evolution of nonstricturing, nonpenetrating (B1) disease at diagnosis and factors related to disease evolution in pediatric CD.

中文翻译:

疾病行为演变的危险因素和生物制剂在减少诊断时非狭窄、非穿透性克罗恩病儿科患者进展中的疗效:韩国的单中心经验。

:最近,克罗恩病 (CD) 的治疗已转变为靶向治疗策略,即通过早期干预来预防疾病进展。我们分析了诊断时非狭窄性、非穿透性 (B1) 疾病的长期演变以及与儿科 CD 疾病演变相关的因素。
更新日期:2021-04-11
down
wechat
bug